Neoplasms Metastasis Completed Phase 3 Trials for Aflibercept (DB08885)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00519285Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerTreatment
NCT00561470Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenTreatment